Cough and cold products for kids still under fire

The FDA in January issued a Public Health Advisory recommending that OTC cough and cold products should not be used to treat infants and children less than 2 years of age because serious and potentially life-threatening side effects can occur from such use.

James G. Dickinson

March 1, 2008

8:55 pm

The FDA in January issued a Public Health Advisoryrecommending that OTC cough and cold products should not be used to treatinfants and children less than 2 years of age because serious and potentiallylife-threatening side effects can occur from such use. The agency is stillreviewing these drugs for their value in older children.

From the March 01, 2008 Issue of MM+M - Medical Marketing and Media

From Our Partners

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

Partner Content

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

The evolution of patient needs and rising consumer expectations are shaping a new era in healthcare — one that calls for a paradigm shift in the pharmaceutical industry's approach to patient support.

Omnichannel activation without omniburden

Partner Content

Omnichannel activation without omniburden

Explore solutions for practically implementing omnichannel approaches into your go-to-market activation.

Taking a patient-centric approach to privacy

Partner Content

Taking a patient-centric approach to privacy

This podcast will explore ways to deliver tailored content that activates, educates and empowers patients while prioritizing privacy and consent.

Living brands: How to build brands in the age of omnichannel

Partner Content

Living brands: How to build brands in the age of omnichannel

This podcast looks at how to leverage advancements in data, technology, AI and content development in order to become a Living Brand.